Covestor’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
7
-10
-59% -$432 ﹤0.01% 2921
2026
Q2
$1K Buy
17
+12
+240% +$441 ﹤0.01% 2408
2026
Q1
$0 Buy
+5
New – ﹤0.01% 2862

Other funds holding RAPP

Covestor's RAPP Position: Q3 2026 in Review

Covestor reduced its Rapport Therapeutics (RAPP) stake by 59% in Q3 2026, selling an estimated $432 and leaving 7 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2921.

Covestor first reported a position in RAPP in Q1 2026 and has held it in 3 quarters since. The position peaked at $1K in Q2 2026. 169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • Covestor held 7 shares of Rapport Therapeutics worth $0 as of Q3 2026.
  • Covestor sold 10 Rapport Therapeutics shares in Q3 2026, an estimated $432.
  • Rapport Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2921 holding.
  • Covestor first reported a position in Rapport Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Covestor's Rapport Therapeutics position peaked at $1K in Q2 2026.
  • 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.